Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

United Health Products (UEEC) Interest Expenses (2016 - 2025)

United Health Products (UEEC) has disclosed Interest Expenses for 14 consecutive years, with $30684.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Expenses rose 303.05% to $30684.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $30684.0, a 2277.71% increase, with the full-year FY2023 number at $8187.0, down 47.2% from a year prior.
  • Interest Expenses was $30684.0 for Q3 2025 at United Health Products, up from $7613.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $389804.0 in Q1 2021 to a low of -$163665.0 in Q4 2021.
  • A 5-year average of $21122.1 and a median of $7613.0 in 2024 define the central range for Interest Expenses.
  • Biggest YoY gain for Interest Expenses was 10308.75% in 2023; the steepest drop was 383.7% in 2023.
  • United Health Products' Interest Expenses stood at -$163665.0 in 2021, then surged by 105.22% to $8547.0 in 2022, then plummeted by 383.7% to -$24248.0 in 2023, then soared by 131.4% to $7613.0 in 2024, then skyrocketed by 303.05% to $30684.0 in 2025.
  • Per Business Quant, the three most recent readings for UEEC's Interest Expenses are $30684.0 (Q3 2025), $7613.0 (Q3 2024), and $7613.0 (Q2 2024).